line_item,period,value,symbol
Tax Effect Of Unusual Items,2025-03-31 00:00:00,0.0,LAURUSLABS.NS
Tax Rate For Calcs,2025-03-31 00:00:00,0.268186,LAURUSLABS.NS
Normalized EBITDA,2025-03-31 00:00:00,11303800000.0,LAURUSLABS.NS
Total Unusual Items,2025-03-31 00:00:00,,LAURUSLABS.NS
Total Unusual Items Excluding Goodwill,2025-03-31 00:00:00,,LAURUSLABS.NS
Net Income From Continuing Operation Net Minority Interest,2025-03-31 00:00:00,3583200000.0,LAURUSLABS.NS
Reconciled Depreciation,2025-03-31 00:00:00,4300900000.0,LAURUSLABS.NS
Reconciled Cost Of Revenue,2025-03-31 00:00:00,24779800000.0,LAURUSLABS.NS
EBITDA,2025-03-31 00:00:00,11303800000.0,LAURUSLABS.NS
EBIT,2025-03-31 00:00:00,7002900000.0,LAURUSLABS.NS
Net Interest Income,2025-03-31 00:00:00,-2160000000.0,LAURUSLABS.NS
Interest Expense,2025-03-31 00:00:00,2160000000.0,LAURUSLABS.NS
Interest Income,2025-03-31 00:00:00,,LAURUSLABS.NS
Normalized Income,2025-03-31 00:00:00,3583200000.0,LAURUSLABS.NS
Net Income From Continuing And Discontinued Operation,2025-03-31 00:00:00,3583200000.0,LAURUSLABS.NS
Total Expenses,2025-03-31 00:00:00,49287700000.0,LAURUSLABS.NS
Rent Expense Supplemental,2025-03-31 00:00:00,,LAURUSLABS.NS
Diluted Average Shares,2025-03-31 00:00:00,,LAURUSLABS.NS
Basic Average Shares,2025-03-31 00:00:00,,LAURUSLABS.NS
Diluted EPS,2025-03-31 00:00:00,,LAURUSLABS.NS
Basic EPS,2025-03-31 00:00:00,,LAURUSLABS.NS
Diluted NI Availto Com Stockholders,2025-03-31 00:00:00,3583200000.0,LAURUSLABS.NS
Net Income Common Stockholders,2025-03-31 00:00:00,3583200000.0,LAURUSLABS.NS
Otherunder Preferred Stock Dividend,2025-03-31 00:00:00,0.0,LAURUSLABS.NS
Net Income,2025-03-31 00:00:00,3583200000.0,LAURUSLABS.NS
Minority Interests,2025-03-31 00:00:00,-200000.0,LAURUSLABS.NS
Net Income Including Noncontrolling Interests,2025-03-31 00:00:00,3583400000.0,LAURUSLABS.NS
Net Income Continuous Operations,2025-03-31 00:00:00,3583400000.0,LAURUSLABS.NS
Tax Provision,2025-03-31 00:00:00,1298800000.0,LAURUSLABS.NS
Pretax Income,2025-03-31 00:00:00,4842900000.0,LAURUSLABS.NS
Other Non Operating Income Expenses,2025-03-31 00:00:00,751000000.0,LAURUSLABS.NS
Special Income Charges,2025-03-31 00:00:00,,LAURUSLABS.NS
Other Special Charges,2025-03-31 00:00:00,,LAURUSLABS.NS
Write Off,2025-03-31 00:00:00,,LAURUSLABS.NS
Net Non Operating Interest Income Expense,2025-03-31 00:00:00,-2160000000.0,LAURUSLABS.NS
Total Other Finance Cost,2025-03-31 00:00:00,,LAURUSLABS.NS
Interest Expense Non Operating,2025-03-31 00:00:00,2160000000.0,LAURUSLABS.NS
Interest Income Non Operating,2025-03-31 00:00:00,,LAURUSLABS.NS
Operating Income,2025-03-31 00:00:00,6251900000.0,LAURUSLABS.NS
Operating Expense,2025-03-31 00:00:00,24507900000.0,LAURUSLABS.NS
Other Operating Expenses,2025-03-31 00:00:00,13011800000.0,LAURUSLABS.NS
Depreciation And Amortization In Income Statement,2025-03-31 00:00:00,4300900000.0,LAURUSLABS.NS
Depreciation Income Statement,2025-03-31 00:00:00,4300900000.0,LAURUSLABS.NS
Research And Development,2025-03-31 00:00:00,,LAURUSLABS.NS
Selling General And Administration,2025-03-31 00:00:00,,LAURUSLABS.NS
Selling And Marketing Expense,2025-03-31 00:00:00,,LAURUSLABS.NS
General And Administrative Expense,2025-03-31 00:00:00,,LAURUSLABS.NS
Rent And Landing Fees,2025-03-31 00:00:00,,LAURUSLABS.NS
Gross Profit,2025-03-31 00:00:00,30759800000.0,LAURUSLABS.NS
Cost Of Revenue,2025-03-31 00:00:00,24779800000.0,LAURUSLABS.NS
Total Revenue,2025-03-31 00:00:00,55539600000.0,LAURUSLABS.NS
Operating Revenue,2025-03-31 00:00:00,55539600000.0,LAURUSLABS.NS
Tax Effect Of Unusual Items,2024-03-31 00:00:00,0.0,LAURUSLABS.NS
Tax Rate For Calcs,2024-03-31 00:00:00,0.288331,LAURUSLABS.NS
Normalized EBITDA,2024-03-31 00:00:00,8038400000.0,LAURUSLABS.NS
Total Unusual Items,2024-03-31 00:00:00,151200000.0,LAURUSLABS.NS
Total Unusual Items Excluding Goodwill,2024-03-31 00:00:00,151200000.0,LAURUSLABS.NS
Net Income From Continuing Operation Net Minority Interest,2024-03-31 00:00:00,1605500000.0,LAURUSLABS.NS
Reconciled Depreciation,2024-03-31 00:00:00,3845800000.0,LAURUSLABS.NS
Reconciled Cost Of Revenue,2024-03-31 00:00:00,24324200000.0,LAURUSLABS.NS
EBITDA,2024-03-31 00:00:00,8038400000.0,LAURUSLABS.NS
EBIT,2024-03-31 00:00:00,4192600000.0,LAURUSLABS.NS
Net Interest Income,2024-03-31 00:00:00,-1829000000.0,LAURUSLABS.NS
Interest Expense,2024-03-31 00:00:00,1829000000.0,LAURUSLABS.NS
Interest Income,2024-03-31 00:00:00,56100000.0,LAURUSLABS.NS
Normalized Income,2024-03-31 00:00:00,1605500000.0,LAURUSLABS.NS
Net Income From Continuing And Discontinued Operation,2024-03-31 00:00:00,1605500000.0,LAURUSLABS.NS
Total Expenses,2024-03-31 00:00:00,46479100000.0,LAURUSLABS.NS
Rent Expense Supplemental,2024-03-31 00:00:00,22600000.0,LAURUSLABS.NS
Diluted Average Shares,2024-03-31 00:00:00,540572391.0,LAURUSLABS.NS
Basic Average Shares,2024-03-31 00:00:00,538758389.0,LAURUSLABS.NS
Diluted EPS,2024-03-31 00:00:00,2.97,LAURUSLABS.NS
Basic EPS,2024-03-31 00:00:00,2.98,LAURUSLABS.NS
Diluted NI Availto Com Stockholders,2024-03-31 00:00:00,1605500000.0,LAURUSLABS.NS
Net Income Common Stockholders,2024-03-31 00:00:00,1605500000.0,LAURUSLABS.NS
Otherunder Preferred Stock Dividend,2024-03-31 00:00:00,0.0,LAURUSLABS.NS
Net Income,2024-03-31 00:00:00,1605500000.0,LAURUSLABS.NS
Minority Interests,2024-03-31 00:00:00,-17200000.0,LAURUSLABS.NS
Net Income Including Noncontrolling Interests,2024-03-31 00:00:00,1622700000.0,LAURUSLABS.NS
Net Income Continuous Operations,2024-03-31 00:00:00,1622700000.0,LAURUSLABS.NS
Tax Provision,2024-03-31 00:00:00,681500000.0,LAURUSLABS.NS
Pretax Income,2024-03-31 00:00:00,2363600000.0,LAURUSLABS.NS
Other Non Operating Income Expenses,2024-03-31 00:00:00,263400000.0,LAURUSLABS.NS
Special Income Charges,2024-03-31 00:00:00,151200000.0,LAURUSLABS.NS
Other Special Charges,2024-03-31 00:00:00,-151200000.0,LAURUSLABS.NS
Write Off,2024-03-31 00:00:00,0.0,LAURUSLABS.NS
Net Non Operating Interest Income Expense,2024-03-31 00:00:00,-1829000000.0,LAURUSLABS.NS
Total Other Finance Cost,2024-03-31 00:00:00,79000000.0,LAURUSLABS.NS
Interest Expense Non Operating,2024-03-31 00:00:00,1829000000.0,LAURUSLABS.NS
Interest Income Non Operating,2024-03-31 00:00:00,56100000.0,LAURUSLABS.NS
Operating Income,2024-03-31 00:00:00,3929200000.0,LAURUSLABS.NS
Operating Expense,2024-03-31 00:00:00,22154900000.0,LAURUSLABS.NS
Other Operating Expenses,2024-03-31 00:00:00,11909800000.0,LAURUSLABS.NS
Depreciation And Amortization In Income Statement,2024-03-31 00:00:00,3845800000.0,LAURUSLABS.NS
Depreciation Income Statement,2024-03-31 00:00:00,3845800000.0,LAURUSLABS.NS
Research And Development,2024-03-31 00:00:00,437600000.0,LAURUSLABS.NS
Selling General And Administration,2024-03-31 00:00:00,2011200000.0,LAURUSLABS.NS
Selling And Marketing Expense,2024-03-31 00:00:00,1344900000.0,LAURUSLABS.NS
General And Administrative Expense,2024-03-31 00:00:00,666300000.0,LAURUSLABS.NS
Rent And Landing Fees,2024-03-31 00:00:00,22600000.0,LAURUSLABS.NS
Gross Profit,2024-03-31 00:00:00,26084100000.0,LAURUSLABS.NS
Cost Of Revenue,2024-03-31 00:00:00,24324200000.0,LAURUSLABS.NS
Total Revenue,2024-03-31 00:00:00,50408300000.0,LAURUSLABS.NS
Operating Revenue,2024-03-31 00:00:00,50408300000.0,LAURUSLABS.NS
Tax Effect Of Unusual Items,2023-03-31 00:00:00,525920.0,LAURUSLABS.NS
Tax Rate For Calcs,2023-03-31 00:00:00,0.2768,LAURUSLABS.NS
Normalized EBITDA,2023-03-31 00:00:00,15557200000.0,LAURUSLABS.NS
Total Unusual Items,2023-03-31 00:00:00,1900000.0,LAURUSLABS.NS
Total Unusual Items Excluding Goodwill,2023-03-31 00:00:00,1900000.0,LAURUSLABS.NS
Net Income From Continuing Operation Net Minority Interest,2023-03-31 00:00:00,7901100000.0,LAURUSLABS.NS
Reconciled Depreciation,2023-03-31 00:00:00,3240800000.0,LAURUSLABS.NS
Reconciled Cost Of Revenue,2023-03-31 00:00:00,28407100000.0,LAURUSLABS.NS
EBITDA,2023-03-31 00:00:00,15559100000.0,LAURUSLABS.NS
EBIT,2023-03-31 00:00:00,12318300000.0,LAURUSLABS.NS
Net Interest Income,2023-03-31 00:00:00,-1380300000.0,LAURUSLABS.NS
Interest Expense,2023-03-31 00:00:00,1228900000.0,LAURUSLABS.NS
Interest Income,2023-03-31 00:00:00,45600000.0,LAURUSLABS.NS
Normalized Income,2023-03-31 00:00:00,7899725920.0,LAURUSLABS.NS
Net Income From Continuing And Discontinued Operation,2023-03-31 00:00:00,7901100000.0,LAURUSLABS.NS
Total Expenses,2023-03-31 00:00:00,47209900000.0,LAURUSLABS.NS
Rent Expense Supplemental,2023-03-31 00:00:00,23000000.0,LAURUSLABS.NS
Diluted Average Shares,2023-03-31 00:00:00,539600487.0,LAURUSLABS.NS
Basic Average Shares,2023-03-31 00:00:00,537730888.0,LAURUSLABS.NS
Diluted EPS,2023-03-31 00:00:00,14.64,LAURUSLABS.NS
Basic EPS,2023-03-31 00:00:00,14.69,LAURUSLABS.NS
Diluted NI Availto Com Stockholders,2023-03-31 00:00:00,7901100000.0,LAURUSLABS.NS
Net Income Common Stockholders,2023-03-31 00:00:00,7901100000.0,LAURUSLABS.NS
Otherunder Preferred Stock Dividend,2023-03-31 00:00:00,0.0,LAURUSLABS.NS
Net Income,2023-03-31 00:00:00,7901100000.0,LAURUSLABS.NS
Minority Interests,2023-03-31 00:00:00,-33200000.0,LAURUSLABS.NS
Net Income Including Noncontrolling Interests,2023-03-31 00:00:00,7934300000.0,LAURUSLABS.NS
Net Income Continuous Operations,2023-03-31 00:00:00,7934300000.0,LAURUSLABS.NS
Tax Provision,2023-03-31 00:00:00,3123000000.0,LAURUSLABS.NS
Pretax Income,2023-03-31 00:00:00,11089400000.0,LAURUSLABS.NS
Other Non Operating Income Expenses,2023-03-31 00:00:00,10400000.0,LAURUSLABS.NS
Special Income Charges,2023-03-31 00:00:00,1900000.0,LAURUSLABS.NS
Other Special Charges,2023-03-31 00:00:00,2100000.0,LAURUSLABS.NS
Write Off,2023-03-31 00:00:00,-4000000.0,LAURUSLABS.NS
Net Non Operating Interest Income Expense,2023-03-31 00:00:00,-1380300000.0,LAURUSLABS.NS
Total Other Finance Cost,2023-03-31 00:00:00,197000000.0,LAURUSLABS.NS
Interest Expense Non Operating,2023-03-31 00:00:00,1228900000.0,LAURUSLABS.NS
Interest Income Non Operating,2023-03-31 00:00:00,45600000.0,LAURUSLABS.NS
Operating Income,2023-03-31 00:00:00,12932300000.0,LAURUSLABS.NS
Operating Expense,2023-03-31 00:00:00,18802800000.0,LAURUSLABS.NS
Other Operating Expenses,2023-03-31 00:00:00,7940400000.0,LAURUSLABS.NS
Depreciation And Amortization In Income Statement,2023-03-31 00:00:00,3240800000.0,LAURUSLABS.NS
Depreciation Income Statement,2023-03-31 00:00:00,3240800000.0,LAURUSLABS.NS
Research And Development,2023-03-31 00:00:00,255900000.0,LAURUSLABS.NS
Selling General And Administration,2023-03-31 00:00:00,1799600000.0,LAURUSLABS.NS
Selling And Marketing Expense,2023-03-31 00:00:00,1161400000.0,LAURUSLABS.NS
General And Administrative Expense,2023-03-31 00:00:00,638200000.0,LAURUSLABS.NS
Rent And Landing Fees,2023-03-31 00:00:00,23000000.0,LAURUSLABS.NS
Gross Profit,2023-03-31 00:00:00,31735100000.0,LAURUSLABS.NS
Cost Of Revenue,2023-03-31 00:00:00,28407100000.0,LAURUSLABS.NS
Total Revenue,2023-03-31 00:00:00,60142200000.0,LAURUSLABS.NS
Operating Revenue,2023-03-31 00:00:00,60142200000.0,LAURUSLABS.NS
Tax Effect Of Unusual Items,2022-03-31 00:00:00,1299200.0,LAURUSLABS.NS
Tax Rate For Calcs,2022-03-31 00:00:00,0.232,LAURUSLABS.NS
Normalized EBITDA,2022-03-31 00:00:00,14105400000.0,LAURUSLABS.NS
Total Unusual Items,2022-03-31 00:00:00,5600000.0,LAURUSLABS.NS
Total Unusual Items Excluding Goodwill,2022-03-31 00:00:00,5600000.0,LAURUSLABS.NS
Net Income From Continuing Operation Net Minority Interest,2022-03-31 00:00:00,8275200000.0,LAURUSLABS.NS
Reconciled Depreciation,2022-03-31 00:00:00,2514900000.0,LAURUSLABS.NS
Reconciled Cost Of Revenue,2022-03-31 00:00:00,22483200000.0,LAURUSLABS.NS
EBITDA,2022-03-31 00:00:00,14111000000.0,LAURUSLABS.NS
EBIT,2022-03-31 00:00:00,11596100000.0,LAURUSLABS.NS
Net Interest Income,2022-03-31 00:00:00,-902400000.0,LAURUSLABS.NS
Interest Expense,2022-03-31 00:00:00,757600000.0,LAURUSLABS.NS
Interest Income,2022-03-31 00:00:00,17200000.0,LAURUSLABS.NS
Normalized Income,2022-03-31 00:00:00,8270899200.0,LAURUSLABS.NS
Net Income From Continuing And Discontinued Operation,2022-03-31 00:00:00,8275200000.0,LAURUSLABS.NS
Total Expenses,2022-03-31 00:00:00,37164000000.0,LAURUSLABS.NS
Rent Expense Supplemental,2022-03-31 00:00:00,23100000.0,LAURUSLABS.NS
Diluted Average Shares,2022-03-31 00:00:00,539169857.0,LAURUSLABS.NS
Basic Average Shares,2022-03-31 00:00:00,536813916.0,LAURUSLABS.NS
Diluted EPS,2022-03-31 00:00:00,15.35,LAURUSLABS.NS
Basic EPS,2022-03-31 00:00:00,15.42,LAURUSLABS.NS
Diluted NI Availto Com Stockholders,2022-03-31 00:00:00,8275200000.0,LAURUSLABS.NS
Net Income Common Stockholders,2022-03-31 00:00:00,8275200000.0,LAURUSLABS.NS
Otherunder Preferred Stock Dividend,2022-03-31 00:00:00,0.0,LAURUSLABS.NS
Net Income,2022-03-31 00:00:00,8275200000.0,LAURUSLABS.NS
Minority Interests,2022-03-31 00:00:00,-47100000.0,LAURUSLABS.NS
Net Income Including Noncontrolling Interests,2022-03-31 00:00:00,8322300000.0,LAURUSLABS.NS
Net Income Continuous Operations,2022-03-31 00:00:00,8322300000.0,LAURUSLABS.NS
Tax Provision,2022-03-31 00:00:00,2514200000.0,LAURUSLABS.NS
Pretax Income,2022-03-31 00:00:00,10838500000.0,LAURUSLABS.NS
Other Non Operating Income Expenses,2022-03-31 00:00:00,13600000.0,LAURUSLABS.NS
Special Income Charges,2022-03-31 00:00:00,5600000.0,LAURUSLABS.NS
Other Special Charges,2022-03-31 00:00:00,12100000.0,LAURUSLABS.NS
Write Off,2022-03-31 00:00:00,-17700000.0,LAURUSLABS.NS
Net Non Operating Interest Income Expense,2022-03-31 00:00:00,-902400000.0,LAURUSLABS.NS
Total Other Finance Cost,2022-03-31 00:00:00,162000000.0,LAURUSLABS.NS
Interest Expense Non Operating,2022-03-31 00:00:00,757600000.0,LAURUSLABS.NS
Interest Income Non Operating,2022-03-31 00:00:00,17200000.0,LAURUSLABS.NS
Operating Income,2022-03-31 00:00:00,11721400000.0,LAURUSLABS.NS
Operating Expense,2022-03-31 00:00:00,14680800000.0,LAURUSLABS.NS
Other Operating Expenses,2022-03-31 00:00:00,5665300000.0,LAURUSLABS.NS
Depreciation And Amortization In Income Statement,2022-03-31 00:00:00,2514900000.0,LAURUSLABS.NS
Depreciation Income Statement,2022-03-31 00:00:00,2514900000.0,LAURUSLABS.NS
Research And Development,2022-03-31 00:00:00,294700000.0,LAURUSLABS.NS
Selling General And Administration,2022-03-31 00:00:00,1637800000.0,LAURUSLABS.NS
Selling And Marketing Expense,2022-03-31 00:00:00,1019800000.0,LAURUSLABS.NS
General And Administrative Expense,2022-03-31 00:00:00,618000000.0,LAURUSLABS.NS
Rent And Landing Fees,2022-03-31 00:00:00,23100000.0,LAURUSLABS.NS
Gross Profit,2022-03-31 00:00:00,26402200000.0,LAURUSLABS.NS
Cost Of Revenue,2022-03-31 00:00:00,22483200000.0,LAURUSLABS.NS
Total Revenue,2022-03-31 00:00:00,48885400000.0,LAURUSLABS.NS
Operating Revenue,2022-03-31 00:00:00,48885400000.0,LAURUSLABS.NS
Tax Effect Of Unusual Items,2021-03-31 00:00:00,,LAURUSLABS.NS
Tax Rate For Calcs,2021-03-31 00:00:00,,LAURUSLABS.NS
Normalized EBITDA,2021-03-31 00:00:00,,LAURUSLABS.NS
Total Unusual Items,2021-03-31 00:00:00,-6100000.0,LAURUSLABS.NS
Total Unusual Items Excluding Goodwill,2021-03-31 00:00:00,-6100000.0,LAURUSLABS.NS
Net Income From Continuing Operation Net Minority Interest,2021-03-31 00:00:00,,LAURUSLABS.NS
Reconciled Depreciation,2021-03-31 00:00:00,,LAURUSLABS.NS
Reconciled Cost Of Revenue,2021-03-31 00:00:00,,LAURUSLABS.NS
EBITDA,2021-03-31 00:00:00,,LAURUSLABS.NS
EBIT,2021-03-31 00:00:00,,LAURUSLABS.NS
Net Interest Income,2021-03-31 00:00:00,,LAURUSLABS.NS
Interest Expense,2021-03-31 00:00:00,,LAURUSLABS.NS
Interest Income,2021-03-31 00:00:00,13100000.0,LAURUSLABS.NS
Normalized Income,2021-03-31 00:00:00,,LAURUSLABS.NS
Net Income From Continuing And Discontinued Operation,2021-03-31 00:00:00,,LAURUSLABS.NS
Total Expenses,2021-03-31 00:00:00,,LAURUSLABS.NS
Rent Expense Supplemental,2021-03-31 00:00:00,20300000.0,LAURUSLABS.NS
Diluted Average Shares,2021-03-31 00:00:00,538124659.0,LAURUSLABS.NS
Basic Average Shares,2021-03-31 00:00:00,535748294.0,LAURUSLABS.NS
Diluted EPS,2021-03-31 00:00:00,18.28,LAURUSLABS.NS
Basic EPS,2021-03-31 00:00:00,18.36,LAURUSLABS.NS
Diluted NI Availto Com Stockholders,2021-03-31 00:00:00,,LAURUSLABS.NS
Net Income Common Stockholders,2021-03-31 00:00:00,,LAURUSLABS.NS
Otherunder Preferred Stock Dividend,2021-03-31 00:00:00,,LAURUSLABS.NS
Net Income,2021-03-31 00:00:00,,LAURUSLABS.NS
Minority Interests,2021-03-31 00:00:00,,LAURUSLABS.NS
Net Income Including Noncontrolling Interests,2021-03-31 00:00:00,,LAURUSLABS.NS
Net Income Continuous Operations,2021-03-31 00:00:00,,LAURUSLABS.NS
Tax Provision,2021-03-31 00:00:00,,LAURUSLABS.NS
Pretax Income,2021-03-31 00:00:00,,LAURUSLABS.NS
Other Non Operating Income Expenses,2021-03-31 00:00:00,,LAURUSLABS.NS
Special Income Charges,2021-03-31 00:00:00,-6100000.0,LAURUSLABS.NS
Other Special Charges,2021-03-31 00:00:00,6100000.0,LAURUSLABS.NS
Write Off,2021-03-31 00:00:00,0.0,LAURUSLABS.NS
Net Non Operating Interest Income Expense,2021-03-31 00:00:00,,LAURUSLABS.NS
Total Other Finance Cost,2021-03-31 00:00:00,102600000.0,LAURUSLABS.NS
Interest Expense Non Operating,2021-03-31 00:00:00,,LAURUSLABS.NS
Interest Income Non Operating,2021-03-31 00:00:00,13100000.0,LAURUSLABS.NS
Operating Income,2021-03-31 00:00:00,,LAURUSLABS.NS
Operating Expense,2021-03-31 00:00:00,,LAURUSLABS.NS
Other Operating Expenses,2021-03-31 00:00:00,,LAURUSLABS.NS
Depreciation And Amortization In Income Statement,2021-03-31 00:00:00,,LAURUSLABS.NS
Depreciation Income Statement,2021-03-31 00:00:00,,LAURUSLABS.NS
Research And Development,2021-03-31 00:00:00,172900000.0,LAURUSLABS.NS
Selling General And Administration,2021-03-31 00:00:00,1405900000.0,LAURUSLABS.NS
Selling And Marketing Expense,2021-03-31 00:00:00,916500000.0,LAURUSLABS.NS
General And Administrative Expense,2021-03-31 00:00:00,489400000.0,LAURUSLABS.NS
Rent And Landing Fees,2021-03-31 00:00:00,20300000.0,LAURUSLABS.NS
Gross Profit,2021-03-31 00:00:00,,LAURUSLABS.NS
Cost Of Revenue,2021-03-31 00:00:00,,LAURUSLABS.NS
Total Revenue,2021-03-31 00:00:00,,LAURUSLABS.NS
Operating Revenue,2021-03-31 00:00:00,,LAURUSLABS.NS
